Tempest Therapeutics, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest
Tempest Therapeutics, Inc. (TPST) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest of $3.00 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2019-11-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest · last filed 2019-11-13
- Tempest Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2018-09-30 was $3.00K.
- Tempest Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2018-06-30 was $4.00K.
- Tempest Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2018-03-31 was $3.00K.
- Tempest Therapeutics, Inc. other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2017 was $2.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2018-09-30 | $3.00K 10-Q · filed 2019-11-13 | $7.00K derived: sum of 2 quarters · filed 2019-11-13 | $10.00K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | $4.00K 10-Q · filed 2019-08-12 | $7.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $3.00K 10-Q · filed 2019-05-15 | |||
| 2017-12-31 | $2.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |